Portable Accessible MRI in Dementia Research: Ethical Considerations About Research Representation and Dementia-Friendly Technology

Overview

Journal J Law Med Ethics

Publisher Cambridge University Press

Date 2025 Jan 31

PMID 39885747

Authors

Eran Klein

S Duke Han

Paul Tuite

W Taylor Kimberly

Mohit Agarwal

Affiliations

Soon will be listed here.

Abstract

The introduction of portable MRI (pMRI) has the potential to directly impact dementia research and ultimately clinical care. In this paper, we explore two ethical challenges facing the introduction of pMRI in dementia research. The first is the need to ensure that pMRI enhances rather than undermines efforts aimed at improving ethnoracial representation in dementia research. The second is the need to implement pMRI in dementia research in a dementia-friendly way that attends to the social context and lived experience of people with dementia.

Citing Articles

Socioeconomic Factors in Brain Research: Increasing Sample Representativeness with Portable MRI.

Farah M J Law Med Ethics. 2025; 52(4):824-829.

PMID: 39885751 PMC: 11798670. DOI: 10.1017/jme.2024.168.

References

Baquet C, Henderson K, Commiskey P, Morrow J . Clinical trials: the art of enrollment. Semin Oncol Nurs. 2008; 24(4):262-9. PMC: 3262589. DOI: 10.1016/j.soncn.2008.08.006. View

Johnson K, Fox N, Sperling R, Klunk W . Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med. 2012; 2(4):a006213. PMC: 3312396. DOI: 10.1101/cshperspect.a006213. View

Hampel H, Elhage A, Cho M, Apostolova L, Nicoll J, Atri A . Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics. Brain. 2023; 146(11):4414-4424. PMC: 10629981. DOI: 10.1093/brain/awad188. View

Mastroianni A, Faden R, Federman D . Women and health research: a report from the Institute of Medicine. Kennedy Inst Ethics J. 1994; 4(1):55-62. DOI: 10.1353/ken.0.0121. View

Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E . Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?. Am J Psychiatry. 2005; 162(4):676-82. DOI: 10.1176/appi.ajp.162.4.676. View

Frisoni G, Fox N, Jack Jr C, Scheltens P, Thompson P . The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010; 6(2):67-77. PMC: 2938772. DOI: 10.1038/nrneurol.2009.215. View

Challen R, Low L, McEntee M . Dementia patient care in the diagnostic medical imaging department. Radiography (Lond). 2018; 24 Suppl 1:S33-S42. DOI: 10.1016/j.radi.2018.05.012. View

Osmanodja F, Rosch J, Knott M, Doerfler A, Grodzki D, Uder M . Diagnostic Performance of 0.55 T MRI for Intracranial Aneurysm Detection. Invest Radiol. 2022; 58(2):121-125. DOI: 10.1097/RLI.0000000000000918. View

Sarracanie M, Lapierre C, Salameh N, Waddington D, Witzel T, Rosen M . Low-Cost High-Performance MRI. Sci Rep. 2015; 5:15177. PMC: 4606787. DOI: 10.1038/srep15177. View

Geethanath S, Vaughan Jr J . Accessible magnetic resonance imaging: A review. J Magn Reson Imaging. 2019; 49(7):e65-e77. DOI: 10.1002/jmri.26638. View

10.

Largent E, Karlawish J, Grill J . Study partners: essential collaborators in discovering treatments for Alzheimer's disease. Alzheimers Res Ther. 2018; 10(1):101. PMC: 6161465. DOI: 10.1186/s13195-018-0425-4. View

11.

Gilmore-Bykovskyi A, Jin Y, Gleason C, Flowers-Benton S, Block L, Dilworth-Anderson P . Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic review. Alzheimers Dement (N Y). 2020; 5:751-770. PMC: 6944728. DOI: 10.1016/j.trci.2019.09.018. View

12.

Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

13.

Lim A, Barnes L, Weissberger G, Lamar M, Nguyen A, Fenton L . Quantification of race/ethnicity representation in Alzheimer's disease neuroimaging research in the USA: a systematic review. Commun Med (Lond). 2023; 3(1):101. PMC: 10368705. DOI: 10.1038/s43856-023-00333-6. View

14.

Hebert L, Weuve J, Scherr P, Evans D . Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013; 80(19):1778-83. PMC: 3719424. DOI: 10.1212/WNL.0b013e31828726f5. View

15.

Ransohoff R, Hafler D, Lucchinetti C . Multiple sclerosis-a quiet revolution. Nat Rev Neurol. 2015; 11(3):134-42. PMC: 4556342. DOI: 10.1038/nrneurol.2015.14. View

16.

Zhao Y, Liao L, Feng H, Chen H, Ning H . Correction to: Enablers and barriers to implementing care quality improvement program in nursing homes in China. BMC Geriatr. 2022; 22(1):1. PMC: 8722059. DOI: 10.1186/s12877-021-02658-0. View

16.

Manietta C, Purwins D, Reinhard A, Knecht C, Roes M . Characteristics of dementia-friendly hospitals: an integrative review. BMC Geriatr. 2022; 22(1):468. PMC: 9158310. DOI: 10.1186/s12877-022-03103-6. View

17.

Shakespeare T, Zeilig H, Mittler P . Rights in Mind: Thinking Differently About Dementia and Disability. Dementia (London). 2017; 18(3):1075-1088. DOI: 10.1177/1471301217701506. View

18.

Dubois B, Feldman H, Jacova C, DeKosky S, Barberger-Gateau P, Cummings J . Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6(8):734-46. DOI: 10.1016/S1474-4422(07)70178-3. View